Potential activity of the purine compounds caffeine and aminophylline on bacteria

Journal of Global Infectious Diseases

Volumn 3, Issue 2, 2011, Pages 133-137

  Al Janabi, Ali Abdul Hussein S ^a  

^a UNIVERSITY OF KERBALA   (Iraq)

Author keywords

Aminophylline; Antibacterial effect; Caffeine; Purine

Indexed keywords

AMINOPHYLLINE; CAFFEINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PARACOCCUS; PARACOCCUS YEEI; PRIORITY JOURNAL; SPECTROPHOTOMETER; STAPHYLOCOCCUS AUREUS; TURBIDITY;

EID: 79959220261     PISSN: 0974777X     EISSN: 09748245     Source Type: Journal    
DOI: 10.4103/0974-777X.81689     Document Type: Article

References (26)

1. Ashihara H, Crozier A. Caffeine: A well known but little mentioned compound in plant science. Trends Plant Sci 2001;6:407-13. (Pubitemid 33145937)
2. Ashihara H, Monteriro AM, Gillies FM, Crozier A. Biosynthesis of caffeine in leaves of coffee. Plan Physiol 1996;111:747-53. (Pubitemid 126450549)
3. Brunton LL, Lazo JS, Parker KL. The pharmacological basis of therapeutics. Goodman and Gilmans. 11th ed. New York: McGraw-Hill; 2006. p. 727-30.
4. Parfitt K. Martindale, the complete drug reference. 32nd ed. Pharmaceutical Press (PhP), U.S.A. 1999.
5. Barnes PJ. Theophylline in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:334-9. (Pubitemid 41699692)
6. Sawynok J. Pharmacological rationale for the clinical use of caffeine. Drugs 1995;49:37-50.
7. Yamaoka-Yano DM, Mazzafera. Catabolism of caffeine and purification of a xanthine oxidase responsible for methyluric acids production in Pseudomonas putida L. Revista 1999;30:62-70. (Pubitemid 29513171)
8. Kawamukai M, Murao K, Utsumi R, Himeno M, Komano T. Cell filamentation in an Escherichia coli K-12 fic mutant caused by theophylline or an adenylate cyclase gene (cya)-containing plasmid. FEMS Microb Lett 1986;34:117-20. (Pubitemid 16162017)
9. Sacks LE, Thompson PA. Increased spore yields of Clostridium perfringens in the presence of methylxanthines. Appl Environ Microbiol 1977;34:189-93. (Pubitemid 8178139)
10. Hosseinzadeh H, Bazzaz BS, Sadati MM. In vitro evaluation of methylxanthines and some antibiotics: Interaction against Staphylococcus aureus and Pseudomonas aeruginosa. Iran Biomed J 2006;10:163-7. (Pubitemid 44049730)
11. Cogo K, Montan MF, Bergamaschi C, Andrade ED, Rosalen PL, Groppo FC. In vitro evaluation of the effect of nicotine, cotinine and caffeine on oral microorganisms. Can J Microbiol 2008;54:501-8. (Pubitemid 351830228)
12. Fleisch F, Zimmermann-Baer U, Zbinden R, Bischoff G, Arlettaz R, Waldvogel K, et al. Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit. Clin Infect Dis 2002;34:767-73. (Pubitemid 34194846)
13. Domínguez MC, de la Rosa M, Borobio MV. Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar. J Antimicrob Chemother 2001;47:391-8. (Pubitemid 32303402)
14. NCCLS. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically; approved standard-sixth edition. NCCLS document M7-A6. NCCLS, Wayne. Pennsylvania, 2003.
15. Holtzman SG. Caffeine as a model drug of abuse. Trends Pharmacol Sci 1990;11:355-6. (Pubitemid 20262458)
16. Griffiths RR, Juliano LM, Chausmer AL. Principles of addiction medicine. 3rd ed. American society of addiction medicine; Philadelphia, 2003. p. 193-224.
17. Raj CV, Dhala S. Effect of naturally occurring xanthines on bacteria: 1- antimicrobial action and potentiating effect on antibiotic spectra. Appl Microbiol 1965;13:432-6.
18. Stearne LE, van Boxtel D, Lemmens N, Goessens WH, Mouton JW, Gyssens IC. Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses. Antimicrob Agents Chemother 2004;48:1688-98. (Pubitemid 38544376)
19. Ikonomidis A, Spanakis N, Poulou A, Pournaras S, Markou F, Tsakris A. Emergence of carbapenem-resistant Enterobacter cloacae carrying VIM- 4 metallo-ß-lactamase and SHV-2a extended-spectrum ß-lactamase in a conjugative plasmid. Microb Drug Resist 2007;13:221-6.
20. Ehrhardt AF, Sanders CC. Beta-lactam resistance amongst Enterobacter species. Antimicrob Agents Chemother 1993;32:1-11. (Pubitemid 24025732)
21. Sandlie I, Solberg K, Kleppe K. The effect of caffeine on cell growth and metabolism of thymidine in Escherichia coli. Mutat Res 1980;73:29-41. (Pubitemid 10014948)
22. Selby CP, Sancar A. Molecular mechanisms of DNA repair inhibition by caffeine. Proc Natl Acad Sci U S A 1990;87:3522-5.
23. Banner KH, Page CP. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 1995;8:996-1000.
24. Biaggioni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. J Pharmacol Exp Ther 1991;258:588-93.
25. Ito K, Lim S, Caramori G, Cosio B, Fan Chung K, Adock IM, et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A 2002;99:8921-6. (Pubitemid 34693659)
26. AL-Janabi AS. Treatment of dermatophytoses by drugs containing some purine compounds. Iraq: Ph.D. Thesis. AL-Mustansiryia Unvi., College of Science; 2004.